[tex=1.429x1.071]6/FL0Glab8AQhcq3I6s+fA==[/tex]葡萄糖苷酶抑制剂 A: Tolbutamide B: Glibenclamide C: 两者均是 D: 两者均不是
[tex=1.429x1.071]6/FL0Glab8AQhcq3I6s+fA==[/tex]葡萄糖苷酶抑制剂 A: Tolbutamide B: Glibenclamide C: 两者均是 D: 两者均不是
The indication of tolbutamide is A: children’s diabetes B: mild or moderate NIDDM C: IDDM D: severe NIDDM E: diabetic patient after pancreatectomy
The indication of tolbutamide is A: children’s diabetes B: mild or moderate NIDDM C: IDDM D: severe NIDDM E: diabetic patient after pancreatectomy
【单选题】下列口服降糖药中,属于胰岛素分泌模式调节剂的是() A. Tolbutamide B. Nateglinide C. Glibenclamide D. Metformin
【单选题】下列口服降糖药中,属于胰岛素分泌模式调节剂的是() A. Tolbutamide B. Nateglinide C. Glibenclamide D. Metformin
可增强胰岛素降血糖作用的药物有() A: Adrenaline B: Hydrocortisone C: Tolbutamide D: Hydrochlorothiazide E: Chlorpropamide(氯磺丙脲)
可增强胰岛素降血糖作用的药物有() A: Adrenaline B: Hydrocortisone C: Tolbutamide D: Hydrochlorothiazide E: Chlorpropamide(氯磺丙脲)
1